Dr. Charles Wykoff @TXRetinaSurgeon comments on the unmet need of patients with #geographicatrophy and the advancem… https://t.co/fHmdsdJBF0
We're thrilled to announce the initiation of our Phase 2 CATALINA study of NGM621 as a potential treatment for… https://t.co/dx71y4TDce
Celebrating with the LGBTQ+ community the landmark #SCOTUS ruling last week that extended workplace discrimination… https://t.co/CBglzW6UD7
Thrilled to welcome Carole Ho, M.D., CMO & Head of Development @Denalitx to our Board! https://t.co/qNJc0lacGP https://t.co/MhUQ5L58Sb
As our nation continues to confront with intensity the historical inequalities and injustices that divide us, we jo… https://t.co/B7SHmjCAZu
We are thrilled to announce the appointment of Siobhan Nolan Mangini as our Chief Financial Officer. Welcome to the… https://t.co/BMzZ9hYzp5
We are taking time to honor all the sacrifices made by our heroes https://t.co/B3N1flnmZy
NGM is thrilled to have Erin Henry (Sr. Director, Ophthalmology) and Joyce Acbay (VP of Regulatory Affairs) join th… https://t.co/sWzGmr09w7
The NGM Second Harvest fundraiser has raised $15,000.00 in donations to support the community during this crisis. D… https://t.co/WEv2b54h3l
NGM is moving forward with purpose during these uncertain times and actively pursuing ambitious R&D goals. We curre… https://t.co/B5aOrU5tIx